» Articles » PMID: 10708417

A Single-amino-acid Substitution of a Tyrosine Residue in the Rubella Virus E1 Cytoplasmic Domain Blocks Virus Release

Overview
Journal J Virol
Date 2000 Mar 9
PMID 10708417
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Rubella virus particles, consisting of a nucleocapsid surrounded by a lipid envelope in which two virus-encoded glycoproteins E1 and E2 are embedded, assemble on intracellular membranes and are secreted from cells, possibly via the cellular secretory pathway. We have recently demonstrated that the cytoplasmic domain of E1 (residues 469 to 481, KCLYYLRGAIAPR) is required for virus release. Alteration of cysteine 470 to alanine did not affect virus release, whereas mutation of leucine 471 to alanine reduced virus production by 90%. In the present study, substitutions of remaining amino acids in the E1 cytoplasmic domain were made in order to investigate the role of each amino acid in regulating rubella virus release. Generated mutants were analyzed in the context of infectious full-length cDNA clone and virus-like particles using combined genetic, biochemical, and electron microscopic approaches. Substitution of a single residue of tyrosine 472 to alanine or tyrosine 473 to serine resulted in a block in virus release without affecting protein transport and virus budding into the lumen of the Golgi complexes. Infectious RNA transcripts bearing these mutations were incapable of forming plaques. Mutants with substitutions at the amino-terminal region (leucine 474, arginine 475, and glycine 476) in the E1 cytoplasmic domain had reduced virus release and small-plaque phenotype, while mutants with substitutions at the carboxy-terminal region (alanine 477, isoleucine 478, alanine 479, proline 480, and arginine 481) had only marginal defects in virus release. Plaque-forming revertants could be isolated from mutants Y472A and Y473S. Sequencing analysis revealed that the substituted serine residue in mutant Y473S reverted to the original tyrosine residue, whereas the substituted alanine residue in mutant Y472A was retained. These results indicate that the E1 cytoplasmic domain modulates virus release in a sequence-dependent manner and that the tyrosine residues are critical for this function. We postulate that residues YYLRG constitute a domain in the E1 tail that may interact with other proteins and this interaction is involved in regulating virus release.

Citing Articles

A single-point mutation in the rubella virus E1 glycoprotein promotes rescue of recombinant vesicular stomatitis virus.

Das P, Gonzalez P, Jangra R, Yin P, Kielian M mBio. 2024; 15(3):e0237323.

PMID: 38334805 PMC: 10936182. DOI: 10.1128/mbio.02373-23.


Molecular and Structural Insights into the Life Cycle of Rubella Virus.

Das P, Kielian M J Virol. 2021; 95(10).

PMID: 33627388 PMC: 8139664. DOI: 10.1128/JVI.02349-20.


Animal and human RNA viruses: genetic variability and ability to overcome vaccines.

Villa T, Abril A, Sanchez S, de Miguel T, Sanchez-Perez A Arch Microbiol. 2020; 203(2):443-464.

PMID: 32989475 PMC: 7521576. DOI: 10.1007/s00203-020-02040-5.


Rubella virus-like replicon particles: analysis of encapsidation determinants and non-structural roles of capsid protein in early post-entry replication.

Claus C, Tzeng W, Liebert U, Frey T J Gen Virol. 2011; 93(Pt 3):516-525.

PMID: 22113006 PMC: 3352351. DOI: 10.1099/vir.0.038984-0.


Analysis of rubella virus capsid protein-mediated enhancement of replicon replication and mutant rescue.

Tzeng W, Matthews J, Frey T J Virol. 2006; 80(8):3966-74.

PMID: 16571813 PMC: 1440428. DOI: 10.1128/JVI.80.8.3966-3974.2006.

References
1.
Oker-Blom C, Ulmanen I, Kaariainen L, Pettersson R . Rubella virus 40S genome RNA specifies a 24S subgenomic mRNA that codes for a precursor to structural proteins. J Virol. 1984; 49(2):403-8. PMC: 255479. DOI: 10.1128/JVI.49.2.403-408.1984. View

2.
Yao J, Strauss E, Strauss J . Interactions between PE2, E1, and 6K required for assembly of alphaviruses studied with chimeric viruses. J Virol. 1996; 70(11):7910-20. PMC: 190863. DOI: 10.1128/JVI.70.11.7910-7920.1996. View

3.
Waxham M, Wolinsky J . A model of the structural organization of rubella virions. Rev Infect Dis. 1985; 7 Suppl 1:S133-9. DOI: 10.1093/clinids/7.supplement_1.s133. View

4.
Clarke D, Loo T, Hui I, Chong P, Gillam S . Nucleotide sequence and in vitro expression of rubella virus 24S subgenomic messenger RNA encoding the structural proteins E1, E2 and C. Nucleic Acids Res. 1987; 15(7):3041-57. PMC: 340714. DOI: 10.1093/nar/15.7.3041. View

5.
Clarke D, Loo T, McDonald H, Gillam S . Expression of rubella virus cDNA coding for the structural proteins. Gene. 1988; 65(1):23-30. DOI: 10.1016/0378-1119(88)90413-1. View